Ameriprise
NDRM

Ameriprise’s NeuroDerm Ltd. Ordinary Shares NDRM Stock Holding History

Ameriprise’s Portfolio NDRM Stock Details NDRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-26,614
Closed -$1.03M – 3840
2017
Q3 		$1.03M Buy
+26,614
New +$979K ﹤0.01% 2947

Other funds holding NDRM

VOAM
Vertex One Asset Management Vancouver, British Columbia, Canada $434M AUM 37.82% 1-Year Est. Return
OTC
Opera Trading Capital Paris, France $419M AUM 0.58% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
FWM
Focused Wealth Management Newburgh, New York $964M AUM 18.71% 1-Year Est. Return

Ameriprise's NDRM Position: Q4 2017 in Review

Ameriprise sold out of NeuroDerm Ltd. Ordinary Shares (NDRM) in Q4 2017, closing a stake of 26,614 shares — an estimated $1.03M sold.

Ameriprise first reported a position in NDRM in Q3 2017 and held it in 1 quarter. The position peaked at $1.03M in Q3 2017. 5 funds tracked by Wall St. Rank hold NDRM as of Q4 2017.

  • Ameriprise reported no remaining NeuroDerm Ltd. Ordinary Shares position as of Q4 2017 after selling out during the quarter.
  • Ameriprise sold 26,614 NeuroDerm Ltd. Ordinary Shares shares in Q4 2017, an estimated $1.03M.
  • Ameriprise first reported a position in NeuroDerm Ltd. Ordinary Shares in Q3 2017 and held it in 1 quarter.
  • Ameriprise's NeuroDerm Ltd. Ordinary Shares position peaked at $1.03M in Q3 2017.
  • 5 funds tracked by Wall St. Rank held NeuroDerm Ltd. Ordinary Shares as of Q4 2017.

Based on Ameriprise's 13F filing for Q4 2017, filed 12 Feb 2018.